I missed your last question, I believe AA is given by the FDA, but it can be requested.
That is based on the original BLA CRL, where MSB requested a type A meeting to request AA.
Now, although MSB has not said it, I do think AA will be discussed 100% in this meeting.
But after the meeting, I *think MSB will need to submit a BLA still. ( I could be wrong, but I imagine, a BLA style application would be needed to cover CMC etc. )
I'm not too sure about the AA process here though, JB or a few other people probably understand it a little better.
2023 The Final Countdown, page-52
-
- There are more pages in this discussion • 3,352 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
0.060(6.15%) |
Mkt cap ! $1.181B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | $1.04 | 96.0¢ | $6.538M | 6.424M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9000 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 118502 | 6 |
View Market Depth
| Last trade - 16.10pm 20/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |